Search
Tempus AI Inc
TEMAdd to Watchlist
52.540USD
+1.980+3.92%
Market hours （ET）Quotes delayed by 15 min
9.43BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-16The current earnings forecast score of Tempus AI Inc is 7.26, ranking 302 out of 388 in the Biotechnology & Medical Research industry. The average price target is 90.00, with a high of 105.00 and a low of 80.00.
Analyst Rating
Based on
19
analysts
Buy
Current Rating
70.963
Target Price
+48.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Tempus AI Inc
TEM
19
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Tempus AI Inc's expected revenue for the next quarter?
Tempus AI Inc's expected revenue is 381.01M.
What is Tempus AI Inc's price target?
Analysts forecast that Tempus AI Inc's price target is USD 90.00, with the highest forecast at USD 105.00 and the lowest forecast at USD 80.00.
How have Tempus AI IncTEM's recent earnings per share performed?
The market expectation was USD -0.70, while Tempus AI IncTEM's earnings per share (EPS) for the previous quarter was USD -0.30. EPS for the next quarter is expected at USD -0.13.
What is the analyst rating for Tempus AI Inc?
Based on the ratings of Tempus AI Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
